Filter
1513
Filtered Results: 1513
Text search:
pharmaceutical
policies
Featured
Recommendations
136
New Publications
439
Language
Document type
No document type
806
Studies & Reports
311
Guidelines
201
Strategic & Response Plan
79
Manuals
63
Training Material
16
Situation Updates
13
Fact sheets
13
Resource Platforms
6
Brochures
3
Infographics
2
Countries / Regions
Kenya
67
Global
62
Ethiopia
60
India
51
South Africa
38
Nigeria
36
Western and Central Europe
36
Uganda
33
Sierra Leone
26
Nepal
25
Liberia
25
Malawi
24
Namibia
23
Ghana
22
Tanzania
22
Bangladesh
22
Zambia
22
Ukraine
20
Africa
20
Rwanda
19
Cambodia
16
Lesotho
15
Latin America and the Carribbean
15
South–East Asia Region
15
Eastern Europe
15
Indonesia
14
Syria
13
Zimbabwe
13
Philippines
13
West and Central Africa
11
Myanmar / Burma
11
East and Southern Africa
10
Botswana
9
Congo, Democratic Republic of
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Eswatini/ Swaziland
7
Cameroon
6
Senegal
6
Asia
6
Thailand
5
Haiti
5
Germany
5
Pakistan
5
Albania
4
Burkina Faso
4
Mozambique
4
Venezuela
4
Western Pacific Region
4
South Sudan
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea
3
USA
3
Vietnam
3
Brazil
3
China
2
Fiji
2
Lithuania
2
Jordan
2
North America
2
Lebanon
2
Egypt
2
Sudan
2
Mali
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Chile
1
Iran
1
Kyrgyzstan
1
Niger
1
Mongolia
1
Bulgaria
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Southern Africa
1
Argentina
1
Papua New Guinea
1
Sri Lanka
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Angola
1
Chad
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
655
Public Health
89
Clinical Guidelines
84
Key Resources
58
Women & Child Health
39
Pharmacy & Technologies
20
Capacity Building
10
Toolboxes
AMR
165
COVID-19
115
Pharmacy
107
Mental Health
82
TB
82
HIV
71
Rapid Response
46
Planetary Health
45
NCDs
38
Global Health Education
32
Caregiver
27
NTDs
25
Conflict
25
Health Financing Toolbox
24
Ebola
13
Refugee
10
Disability
8
Specific Hazards
7
Natural Hazards
7
Polio
6
Zika
3
Social Ethics
2
Health Financing
2
Cholera
1
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Phil. Trans. R. Soc. B (2010) 365, 2959–2971; doi:10.1098/rstb.2010.0143.
Agricultural ecosystems provide humans with food, forage, bioenergy and pharmaceuticals and are essential to human wellbeing. These systems rely on ecosystem services provided by natural ecosystems, including pollination, b...
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence of catastrophic health spending and impoverishing ...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
1. Provide treatment for mental disorders in primary care
2. Ensure wider accessibility to essential psychotropic drugs
3. Provide care in the community
4. Educate the public
5. Involve communities, families and consumers
6. Establish national policies, programmes and legislation on mental heal...
The mission of the Women’s Health Council is to inform and influence the development of health policy to ensure the maximum health and social gain for women in Ireland.
Its membership is representative of a wide range of expertise and interest in women’s health.
The Women’s Health Council ...
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines polic...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu...
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and ensure the implementation of policies and p...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
